Hematology & Blood Cancer
Advertisement
Understanding critical symptoms in the “CRAB” acronym can enable oncology nurses to educate patients and caregivers.
Up to 50% of patients have renal insufficiency at the time of multiple myeloma diagnosis.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains.
Blood Cancer Awareness Month represents a critical opportunity to provide education on early signs and symptoms.
Lisa Hwa, APRN, CNP, DNP, MS, speaks about her work as an APP and the importance of National APP Week.
Amy Pierre, RN, BSN, ANP-BC, shares what the annual observance means to her and the field as a whole.
Researchers evaluated the renal status of more than 250 patients receiving TKIs in a chronic myeloid leukemia clinic.
Researchers presented the results of the observational study at the 2024 SOHO Meeting.
Research presented at the Annual Meeting of the Society of Hematologic Oncology provided insights on outcomes and risks.
Hear about an NP's journey into hematologic oncology and how she has seen the treatment landscape evolve.
An analysis of the RESPONSE and RESPONSE-2 studies further supports the benefit of ruxolitinib in these patients.
Learn how nurses can educate their peers, their patients, and the public about blood cancers and their symptoms.
A study of more than 10,000 patients illuminated the characteristics and needs of patients who are in remission.
Learn how an innovative rehabilitation model improved clinical outcomes and patient satisfaction with nursing care.
Learn about the diverse unmet needs and potential solutions related to the experiences of patients and caregivers.
New research shows that major depressive disorder is associated with certain outcomes in this population of patients.
Nurses, nurse administrators, physician assistants, and oncologists/hematologists shared their insights with researchers.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, shares 3 key tips for nurses caring for these patients.
A subgroup analysis of CARTITUDE-4 evaluated ciltacabtagene autoleucel in functionally high-risk multiple myeloma.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.